Choosing Multiple Myeloma Regimens

Gabriel Hinojosa, PharmD, BCOP, provides insights on selecting the best treatment regimen, and considers comorbidities, adverse events, and therapy modifications in multiple myeloma treatment.

Related Keywords

Gabriel Hinojosa , ,Multiple Myeloma ,Autologous Transplant ,Eligibility Factors ,Treatment Shifts ,Stem Cell Transplantation ,Myeloma Therapy ,Dvrd ,Pfas ,Griffin Trial ,Perseus Trial ,